Place of Sulodexide in the Renoprotektivе Therapy of Patients with Chronic Kidney Disease
Abstract
The problem of chronic kidney disease is not only medical but also social and economic importance. Since these diseases annually kill millions and lead to severe complications associated not only with disability but also the need for high-cost treatment.
Therefore, an important aspect of therapy in patients with chronic kidney disease is to prevent development and progression of renal failure. Consequently, a major focus of prevention is to conduct renoprotektivе therapy. In connection with what is necessary to develop new therapies aimed at the basic pathophysiological mechanisms of development of nephropathy. One of the new directions of development in renoprotektivе therapy is the use of the drug in the practice of Sulodexide. Considering the basic properties of the drug, currently based on the Nephrology department conducted a clinical study of the properties of Sulodexide and already received the first clinical cases of the positive effect of the therapy Sulodexide. Consequently, we can already assume that this drug has renoprotektivе action.
About the Authors
M. M. BatyushinRussian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
A. A. Galushkin
Russian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
A. S. Litvinov
Russian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
N. A. Sadovnichaya
Russian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
D. S. Tsvetkov
Russian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
V. N. Poganeva
Russian Federation
Department of Internal Diseases № 1
29 Nakhichevansky st., Rostov-on-Don, 344022
References
1. Renal Association. UK Renal Registry. The Eighth Annual Report. December 2005.
2. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2007 гг. //Нефрология и диализ. - 2009. - Т.11, №3. - С. 144-233.
Review
For citations:
Batyushin M.M., Galushkin A.A., Litvinov A.S., Sadovnichaya N.A., Tsvetkov D.S., Poganeva V.N. Place of Sulodexide in the Renoprotektivе Therapy of Patients with Chronic Kidney Disease. Medical Herald of the South of Russia. 2012;(1):72-73. (In Russ.)